ArticleJournal of diabetes science and technology2021
Racial Disparities in Diabetes Technology Use and Outcomes in Type 1 Diabetes in a Safety-Net Hospital.
Article in Journal of diabetes science and technology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06638099 (Increasing Use of Continuous Glucose Monitors Among Patients With Type 2 Diabetes), which is not on this map. Cited by 42 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Increasing Use of Continuous Glucose Monitors Among Patients With Type 2 Diabetes
Who cites it
42 citing papers in PubMed, 56 citations in OpenAlex.
- Greater Telehealth Use Results in Increased Visit Frequency and Lower Physician Related-Distress in Adolescents and Young Adults With Type 1 Diabetes.Journal of diabetes science and technology · 2023Trial
- US race/ethnic disparities in diabetes technologies: a systematic review and meta-analysis of 950 000 individuals.Journal of the Endocrine Society · 2026Review
- Continuous Glucose Monitoring Intervention for Hispanic Adults With Type 1 Diabetes Receiving Care in a Federally Qualified Health Center: Protocol for a Mixed Methods, Pragmatic Pilot Randomized Controlled Trial.JMIR research protocols · 2026Article
- Accelerating care, capacity and equity in automated insulin delivery systems for New Zealanders with type 1 diabetes: the ACCESS-AID study protocol.Journal of diabetes and metabolic disorders · 2026Article
- Beyond access: Racial and socioeconomic disparities in device use among youth with type 1 diabetes.SSM. Qualitative research in health · 2026Article
- Glycaemic benefits of smart insulin pens in socioeconomically deprived individuals: a single-Centre study.Irish journal of medical science · 2026Observational
- Impact of social vulnerability on glycemic control and diabetes technology use in youth with type 1 diabetes.BMC endocrine disorders · 2026Article
- Promoting Access to Continuous Glucose Monitoring among Patients with Type 2 Diabetes in Rural Areas: A Report from the Field.Journal of health care for the poor and underserved · 2026Article
- Improving Outcomes for Black Adults with Diabetes: The Power of Peer Support in the Multidisciplinary Care Team.Journal of multidisciplinary healthcare · 2026Review
- Navigating Continuous Glucose Monitoring Adoption: Insights From Hispanic Adults With Insulin-Treated Type 2 Diabetes.Journal of diabetes research · 2026Article
- Disparities in access to and use of diabetes technologies and therapeutics: a narrative review.Diabetologia · 2025Review
- An Ethical Framework for Addressing the Differential Impact of Systemic Racism and Inequities on Type 1 and Type 2 Diabetes Mellitus in Youth in the United States.Hormone research in paediatrics · 2025Review
- Remote Physiologic Monitoring Use Among Medicare Patients: Differences By Race, Ethnicity.Health affairs (Project Hope) · 2025Article
- Trends and Disparities in Technology Use and Glycemic Control in Type 1 Diabetes.JAMA network open · 2025Article
- Social disadvantage and technology use among adults with type 1 diabetes in Quebec: A cross-sectional study using data from the Canadian T1D (BETTER) Registry.Diabetes, obesity & metabolism · 2025Article
- Disparities in technology utilization among youth with type 1 diabetes across diverse racial and socioeconomic backgrounds.BMJ open diabetes research & care · 2025Article
- Diabetes Care and Education: A Look Backward and Forward.TouchREVIEWS in endocrinology · 2025Review
- Barriers to recruitment of an observational SARS-CoV-2 emergency department cohort at Boston Medical Center.BMC emergency medicine · 2025Observational
- Article
- "I Just Wish That It Would Be Easier": Caregivers' Perspectives on Barriers and Proposed Solutions to Diabetes Technology Use for Non-Hispanic Black and Hispanic Youth With Type 1 Diabetes.Diabetes spectrum : a publication of the American Diabetes Association · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
Abstract
backgroundLimited data exist regarding diabetes technology use among adults with type 1 diabetes (T1D) in urban racially/ethnically diverse safety-net hospitals. We examined racial/ethnic differences in the use of continuous glucose monitor (CGM) and continuous subcutaneous insulin infusion (CSII) in this setting.
methodsA retrospective review of 227 patients ≥ 18 years of age with T1D seen in an urban, safety-net endocrinology clinic during 2016-2017 was completed (mean age: 39; 80% English-speaking; 50% had public insurance). Diabetes technology use, defined as either CGM or CSII or both CGM and CSII, and clinical outcomes were examined by race/ethnicity.
resultsOverall, 30% used CGM and 26% used CSII. After adjusting for age, language, insurance, and annual income, diabetes technology use in non-White patients was significantly lower than in White patients, predominantly lower in Black (aOR 0.25 [95% CI 0.11-0.56]) and patients identified as other race/ethnicity (aOR 0.30 [95% CI 0.11-0.77]). At the highest household income level (≥$75,000/y), Black and Hispanic individuals were significantly less likely than White individuals to use diabetes technology (
conclusionsRacial/ethnic disparities in diabetes technology use and glycemic control were observed even after adjusting for sociodemographic factors. Further research should explore barriers to accessing diabetes technology in non-White populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.